Normal Interferon Levels in Healthy Adults 80+
Part of Immune system & allergy clinical trials.
This study aims to find normal levels of interferon (a natural protein that helps fight viruses) in healthy people aged 80 and older. It will help doctors better understand what is 'normal' for older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 80 years old or older
- You either get care at Charpennes geriatric hospital, accompany someone there, or saw the study ad in local press in Lyon
- You weigh at least 45 kg (about 99 pounds)
- You live in the Lyon area
- You do not have symptoms of an active infection (like fever or cough) today
- You do not have an autoimmune disease like lupus or rheumatoid arthritis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how infections and the aging immune system affect older adults. It compares people with an infection to healthy volunteers to understand how the body fights germs as we age.
This study looks at how the immune system works in older adults and how it relates to infections. It aims to develop better ways to prevent and manage infectious diseases in people over 60.
This study looks at a protein called type I interferon, which is often too high in people with autoimmune diseases. The goal is to better understand how it relates to these conditions, which may help improve future treatments.
This study examines how the body's natural defense system (specifically a type of immune protein) responds to common respiratory viruses like flu and cold in older adults. Researchers will analyze nasal samples that are already being collected as part of routine care to better understand why older people sometimes have different immune responses to these infections.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
This study looks at how the body's immune system responds to severe injury or illness by measuring a substance called interferon-gamma (IFN-γ) in the blood. The goal is to better understand infection risk and help doctors improve care for patients in the intensive care unit (ICU).
Hear when a new Immunosenescence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.